Quidditas developed a novel genome editing platform which permits a controled genetic recombination.
About
Genome editing-based therapies become the predominant technology of the 21st century with promising statements about genetic diseases treatments. Genome editing tools recently emerged but they suffer from an absence of standardization and their applications remain limited.
In this context, Quidditas developed a novel genome editing platform which permits a controled genetic recombination.
Compatible with a larger scope of applications, from bioprocess improvement to genetic disorders treatment, this revolutionary technique will have a major impact in the synthetic Bio field.
In this context, Quidditas developed a novel genome editing platform which permits a controled genetic recombination.
Compatible with a larger scope of applications, from bioprocess improvement to genetic disorders treatment, this revolutionary technique will have a major impact in the synthetic Bio field.